Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
BIOHARVEST SCIENCES INC.
Revenue grew 37.0% YoY; but unprofitable (net margin -32.3%).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
BIOHARVEST SCIENCES INC. shows $34.5M in FY2025 revenue (+37.0% YoY), a -32.3% net margin, and -43.8% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001723464, latest 6-K filed 2026-05-28) · EODHD · rules-based read · as of 6/18/2026, 12:42:27 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | $12.7M | $25.2M | $34.5M |
| Gross profit | — | — | — |
| Operating income | -$9.97M | -$6.99M | -$5.58M |
| Net income | -$12.6M | -$12.9M | -$11.1M |
| Diluted EPS | — | — | — |
| Net margin | -99.1% | -51.3% | -32.3% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median